Who invested in Everest Medicines

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 6 months ago

Funding summaryUpdated 26 Oct 2026

$6.8Mraised across 1 round since 2026, from 1 source

Latest round: Secondary, $6.8MMay 2026
Investors: 4

See who backed them

The rounds

May 2026
Secondary$6.8M
Source recorded

Everyone who backed them

RA Capital ManagementPrivate equity1round

Hill House CapitalFamily office1round

Janus Henderson InvestorsPrivate equity1round

Pavilion CapitalPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Everest Medicines as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Decheng CapitalVC firmPer its own site

Quick answers about Everest Medicines

Who invested in Everest Medicines?

Everest Medicines's investors include RA Capital Management, Hill House Capital, Janus Henderson Investors and Pavilion Capital.

How much has Everest Medicines raised?

Everest Medicines has raised $6.8M across 1 round since 2026.

When did Everest Medicines last raise?

Everest Medicines's most recent round was a Secondary of $6.8M in May 2026.

What was Everest Medicines's biggest round?

Its most recent round, $6.8M in May 2026, is also its largest on record.

Who backed Everest Medicines first?

Everest Medicines's first round on record, in May 2026, was backed by RA Capital Management, Hill House Capital and Janus Henderson Investors and 1 others.